Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
- Peter Lynch
What is insider trading>>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2
(Amendment No. 4)*
IQVIA HOLDINGS INC.
(Name of Issuer)
Common Stock, $0.01 par value per share
(Title of Class of Securities)
46266C105
(CUSIP Number)
December 31, 2017
(Date of Event Which Requires Filing this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).
CUSIP No. | 46266C105 |
1 | NAMES OF REPORTING PERSONS
Dennis B. Gillings, CBE | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
5 | SOLE VOTING POWER
9,071,839 | ||||
6 | SHARED VOTING POWER
154,067 (1) | |||||
7 | SOLE DISPOSITIVE POWER
9,071,839 | |||||
8 | SHARED DISPOSITIVE POWER
154,067 (1) |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,225,906 (1) | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☒
| |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.4% (2) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN |
(1) | Includes the following shares over which Dr. Dennis Gillings may be deemed to exercise shared voting and investment control: (i) 84,067 shares held by GFEF Limited Partnership, of which Dr. Dennis Gillings is the general partner; and (ii) 70,000 shares held by Dennis & Mireille Gillings Foundation, of which Dr. Dennis Gillings is the president and director. Dr. Dennis Gillings disclaims beneficial ownership of all shares of common stock held by such persons, except to the extent of his pecuniary interest therein. |
(2) | Based on 207,987,870 shares of common stock outstanding as of November 20, 2017 (reflecting 210,487,870 shares of common stock of the Issuer outstanding as of November 20, 2017, less 2,500,000 shares of common stock repurchased by the Issuer in November 2017, as reported by the Issuer in its Prospectus Supplement filed pursuant to Rule 424(b)(7) on November 29, 2017). |
Page 2
CUSIP No. | 46266C105 |
1 | NAMES OF REPORTING PERSONS
Mireille Gillings, Ph.D. | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
0 | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
0 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 (1) | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐
| |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN |
(1) | Dr. Mireille Gillings, who is married to Dr. Dennis Gillings, retired from the Issuers board of directors effective as of November 5, 2016. As such, Dr. Mireille Gillings is no longer deemed an indirect beneficial owner of the shares beneficially owned by Dr. Dennis Gillings. |
Page 3
CUSIP No. | 46266C105 |
1 | NAMES OF REPORTING PERSONS
Susan Gillings Gross | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
5 | SOLE VOTING POWER
23,678 (1) | ||||
6 | SHARED VOTING POWER
400,000 (2) | |||||
7 | SOLE DISPOSITIVE POWER
23,678 (1) | |||||
8 | SHARED DISPOSITIVE POWER
400,000 (2) |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
423,678 (1) (2) | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐
| |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.2% (3) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN |
(1) | Ms. Gross directly beneficially owns 23,678 shares of common stock. |
(2) | Ms. Gross may be deemed to indirectly beneficially own 400,000 shares held by GF Investment Associates LP by virtue of her position as manager of GF Association LLC, the general partner of GF Investment Associates LP. Ms. Gross disclaims beneficial ownership of all shares of common stock held by GF Investment Associates LP, except to the extent of her pecuniary interest therein. |
(3) | Based on 207,987,870 shares of common stock outstanding as of November 20, 2017 (reflecting 210,487,870 shares of common stock of the Issuer outstanding as of November 20, 2017, less 2,500,000 shares of common stock repurchased by the Issuer in November 2017, as reported by the Issuer in its Prospectus Supplement filed pursuant to Rule 424(b)(7) on November 29, 2017). |
Page 4
CUSIP No. | 46266C105 |
1 | NAMES OF REPORTING PERSONS
GF Investment Associates LP | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
400,000 | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
400,000 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
400,000 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐
| |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.2% (1) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN |
(1) | Based on 207,987,870 shares of common stock outstanding as of November 20, 2017 (reflecting 210,487,870 shares of common stock of the Issuer outstanding as of November 20, 2017, less 2,500,000 shares of common stock repurchased by the Issuer in November 2017, as reported by the Issuer in its Prospectus Supplement filed pursuant to Rule 424(b)(7) on November 29, 2017). |
Page 5
CUSIP No. | 46266C105 |
1 | NAMES OF REPORTING PERSONS
GFEF Limited Partnership | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
North Carolina |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
84,067 (1) | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
84,067 (1) |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
84,067 (1) | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐
| |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
< 0.1% (2) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN |
(1) | Includes 84,067 shares of common stock directly beneficially owned by GFEF Limited Partnership. Dr. Dennis Gillings may be deemed to exercise shared voting and investment control over the 84,067 shares held by the GFEF Limited Partnership as its general partner. Dr. Dennis Gillings disclaims beneficial ownership of all shares of common stock held by such person, except to the extent of his pecuniary interest therein. |
(2) | Based on 207,987,870 shares of common stock outstanding as of November 20, 2017 (reflecting 210,487,870 shares of common stock of the Issuer outstanding as of November 20, 2017, less 2,500,000 shares of common stock repurchased by the Issuer in November 2017, as reported by the Issuer in its Prospectus Supplement filed pursuant to Rule 424(b)(7) on November 29, 2017). |
Page 6
CUSIP No. | 46266C105 |
1 | NAMES OF REPORTING PERSONS
Dennis & Mireille Gillings Foundation | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
North Carolina |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
70,000 | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
70,000 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,000 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐
| |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
< 0.1% (1) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO |
(1) | Based on 207,987,870 shares of common stock outstanding as of November 20, 2017 (reflecting 210,487,870 shares of common stock of the Issuer outstanding as of November 20, 2017, less 2,500,000 shares of common stock repurchased by the Issuer in November 2017, as reported by the Issuer in its Prospectus Supplement filed pursuant to Rule 424(b)(7) on November 29, 2017). |
Page 7
Item 1(a). | Name of Issuer: | |||
IQVIA Holdings Inc., renamed from Quintiles IMS Holdings, Inc., on November 6, 2017. | ||||
Item 1(b). | Address of Issuers Principal Executive Offices: | |||
4820 Emperor Boulevard Durham, North Carolina 27703 | ||||
Item 2(a). | Name of Person Filing: | |||
Dennis B. Gillings, CBE (Dr. Dennis Gillings) Mireille Gillings, Ph.D. (Dr. Mireille Gillings) Susan Gillings Gross (Ms. Gross) GF Investment Associates LP GFEF Limited Partnership Dennis & Mireille Gillings Foundation (collectively, the Reporting Persons)
The Reporting Persons have entered into a joint filing agreement, a copy of which is attached as Exhibit 99.1 hereto, related to the joint filing of Amendment No. 2 to Schedule 13G and each subsequent amendment to the Schedule 13G in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (the Exchange Act). | ||||
Item 2(b). | Address of Principal Business Office or, if none, Residence: | |||
4820 Emperor Boulevard Durham, North Carolina 27703 | ||||
Item 2(c). | Citizenship: | |||
All Reporting Persons that are individuals are citizens of the Unites States.
GF Investment Associates LP is a Delaware limited partnership. GFEF Limited Partnership is a North Carolina limited partnership. Dennis & Mireille Gillings Foundation is organized under the laws of North Carolina. | ||||
Item 2(d). | Title of Class of Securities: | |||
Common Stock, $0.01 par value per share | ||||
Item 2(e). | CUSIP Number: | |||
46266C105 | ||||
Item 3. | If this statement is filed pursuant to §§ 240.13d1(b) or 240.13d2(b) or (c), check whether the person filing is a: | |||
Not applicable. This Amendment No. ;4 to Schedule 13G/A (this Schedule 13G/A) is filed pursuant to Rule 13d-1(d) under the Exchange Act. | ||||
Item 4. | Ownership. | |||
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. | ||||
(a) | Amount beneficially owned: |
Dennis B. Gillings, CBE |
9,225,906 | (1) | ||
Mireille Gillings, Ph.D. |
0 | (2) | ||
Susan Gillings Gross |
423,678 | (3) | ||
GF Investment Associates LP |
400,000 | |||
GFEF Limited Partnership |
84,067 | |||
Dennis & Mireille Gillings Foundation |
70,000 |
Page 8
(b) | Percent of class (based on 210,487,870 shares of common stock outstanding as of November 20, 2017, as reported by the Issuer in its Prospectus Supplement filed pursuant to Rule 424(b)(7) on November 29, 2017): |
Dennis B. Gillings, CBE |
4.4 | % (1) | ||
Mireille Gillings, Ph.D. |
0.0 | % (2) | ||
Susan Gillings Gross |
0.2 | % (3) | ||
GF Investment Associates LP |
0.2 | % | ||
GFEF Limited Partnership |
< 0.1 | % | ||
Dennis & Mireille Gillings Foundation |
< 0.1 | % |
(c) | Number of shares as to which the person has: |
(i) |
Sole power to vote or to direct the vote: |
Dennis B. Gillings, CBE |
9,071,839 | |||
Mireille Gillings, Ph.D. |
0 | (2) | ||
Susan Gillings Gross |
23,678 | |||
GF Investment Associates LP |
0 | |||
GFEF Limited Partnership |
0 | |||
Dennis & Mireille Gillings Foundation |
0 |
(ii) |
Shared power to vote or to direct the vote |
Dennis B. Gillings, CBE |
154,067 | (1) | ||
Mireille Gillings, Ph.D. |
0 | (2) | ||
Susan Gillings Gross |
400,000 | (4) | ||
GF Investment Associates LP |
400,000 | (4) | ||
GFEF Limited Partnership |
84,067 | (5) | ||
Dennis & Mireille Gillings Foundation |
70,000 | (6) |
(iii) |
Sole power to dispose or to direct the disposition of |
Dennis B. Gillings, CBE |
9,071,839 | |||
Mireille Gillings, Ph.D. |
0 | (2) | ||
Susan Gillings Gross |
23,678 | |||
GF Investment Associates LP |
0 | |||
GFEF Limited Partnership |
0 | |||
Dennis & Mireille Gillings Foundation |
0 |
(iv) |
Shared power to dispose or to direct the disposition of |
Dennis B. Gillings, CBE |
154,067 | (1) | ||
Mireille Gillings, Ph.D. |
0 | (2) | ||
Susan Gillings Gross |
400,000 | (4) | ||
GF Investment Associates LP |
400,000 | (4) | ||
GFEF Limited Partnership |
84,067 | (5) | ||
Dennis & Mireille Gillings Foundation |
70,000 | (6) |
(1) | Includes the following shares over which Dr. Dennis Gillings may be deemed to exercise shared voting and investment control: (i) 84,067 shares held by GFEF Limited Partnership, of which Dr. Dennis Gillings is the general partner; and (ii) 70,000 shares held by Dennis & Mireille Gillings Foundation of which Dr. Dennis Gillings is the president and director. Dr. Dennis Gillings disclaims beneficial ownership of all shares of common stock held by such persons, except to the extent of his pecuniary interest therein. |
Page 9
(2) | Dr. Mireille Gillings, who is married to Dr. Dennis Gillings, retired from the Issuers board of directors effective as of November 5, 2015. As such, Dr. Mireille Gillings is no longer deemed an indirect beneficial owner of the shares beneficially owned by Dr. Dennis Gillings. | |||
(3) | Includes 23,678 shares held directly by Ms. Gross and 400,000 shares held by GF Investment Associates LP by virtue of her position as manager of GF Association LLC, the general partner of GF Investment Associates LP. Ms. Gross disclaims beneficial ownership of all shares of common stock held by GF Investment Associates LP, except to the extent of her pecuniary interest therein. | |||
(4) | Ms. Gross is the manager of GF Association LLC, the general partner of GF Investment Associates LP, and may be deemed to share voting and investment control over the shares held by GF Investment Associates LP. | |||
(5) | Dr. Dennis Gillings is the general partner of GFEF Limited Partnership and may be deemed to share voting and investment control over the shares held by GFEF Limited Partnership. | |||
(6) | Dr. Dennis Gillings is the president and director of Dennis & Mireille Gillings Foundation and may be deemed to share voting and investment control over the shares held by Dennis & Mireille Gillings Foundation. | |||
Item 5. | Ownership of Five Percent or Less of a Class. | |||
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be beneficial owner of more than 5 percent of the class of securities, check the following ☒. | ||||
Item 6. | Ownership of More than Five Percent on Behalf of Another Person. | |||
Not applicable. | ||||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |||
Not applicable. | ||||
Item 8. | Identification and Classification of Members of the Group. | |||
See item 4. | ||||
Item 9. | Notice of Dissolution of Group. | |||
Not applicable. | ||||
Item 10. | Certifications. | |||
Not applicable. |
Page 10
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 14, 2018
DENNIS B. GILLINGS, CBE |
By: | /s/ Dennis B. Gillings | |
Name: | Dennis B. Gillings, CBE |
MIREILLE GILLINGS, PH.D. |
By: | /s/ Mireille Gillings | |
Name: | Mireille Gillings, Ph.D. |
SUSAN GILLINGS GROSS |
By: | /s/ Susan Gillings Gross | |
Name: | Susan Gillings Gross |
GF INVESTMENT ASSOCIATES LP | ||
By: GF Association LLC, its general partner |
By: | /s/ Susan Gillings Gross | |
Name: | Susan Gillings Gross | |
Title: | Sole Manager |
GFEF LIMITED PARTNERSHIP |
By: | /s/ Dennis B. Gillings | |
Name: | Dennis B. Gillings | |
Title: | General Partner |
DENNIS & MIREILLE GILLINGS FOUNDATION |
By: | /s/ Dennis B. Gillings | |
Name: | Dennis B. Gillings | |
Title: | President |
Page 11
MATERIALS TO BE FILED AS EXHIBITS
Exhibit 99.1 | Joint Filing Agreement, dated as of February 11, 2016, among the Reporting Persons. |
Page 12